Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)

NCT05247255 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05247255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
March 29, 2022
Completion date
January 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative